Dr. Lisa Drakeman, Ph.D.
is Chief Executive Officer of Genmab A/S, a Copenhagen-based biopharmaceutical company that develops monoclonal antibodies for the treatment of a wide range of life threatening and debilitating diseases.

She has been named "Advocate of the Year for 1995" by the national Biotechnology Industry Organization and "Industry Woman of the Year for 1996" by BCNJ. . Dr. Lisa Drakeman is Trustee and Chief Financial Officer of the Prosperity New Jersey public-private partnership.